CIP
GSK icon

Chartwell Investment Partners’s GSK GSK Stock Holding History

Chartwell Investment Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,775
Closed -$280K – 406
2019
Q4 		$280K Buy
4,775
+199
+4% +$11.1K 0.01% 399
2019
Q3 		$244K Hold
4,576
– – 0.01% 401
2019
Q2 		$229K Sell
4,576
-14,812
-76% -$743K 0.01% 406
2019
Q1 		$1.01M Sell
19,388
-219,702
-92% -$11M 0.03% 387
2018
Q4 		$11.4M Sell
239,090
-22,704
-9% -$1.12M 0.4% 81
2018
Q3 		$13.1M Buy
261,794
+10,152
+4% +$516K 0.39% 81
2018
Q2 		$12.7M Sell
251,642
-82,776
-25% -$4.17M 0.38% 96
2018
Q1 		$16.3M Buy
334,418
+44,374
+15% +$2.07M 0.56% 48
2017
Q4 		$12.9M Sell
290,044
-174,728
-38% -$8.07M 0.44% 80
2017
Q3 		$23.6M Sell
464,772
-8,196
-2% -$416K 0.8% 9
2017
Q2 		$25.5M Sell
472,968
-7,728
-2% -$412K 0.96% 4
2017
Q1 		$25.3M Buy
480,696
+80,663
+20% +$4.09M 0.92% 5
2016
Q4 		$19.3M Sell
400,033
-59,200
-13% -$2.92M 0.66% 35
2016
Q3 		$24.8M Buy
459,233
+9,845
+2% +$540K 0.44% 51
2016
Q2 		$24.3M Buy
449,388
+376,804
+519% +$19.9M 0.43% 48
2016
Q1 		$3.68M Buy
72,584
+3,064
+4% +$153K 0.07% 234
2015
Q4 		$3.51M Buy
+69,520
New +$3.54M 0.07% 239
2014
Q3 		– Sell
-47,096
Closed -$3.15M – 354
2014
Q2 		$3.15M Sell
47,096
-2,480
-5% -$168K 0.07% 278
2014
Q1 		$3.31M Buy
49,576
+472
+1% +$31.9K 0.07% 271
2013
Q4 		$3.28M Buy
+49,104
New +$3.18M 0.07% 276

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Chartwell Investment Partners's GSK Position: Q1 2020 in Review

Chartwell Investment Partners sold out of GSK (GSK) in Q1 2020, closing a stake of 4,775 shares — an estimated $280K sold.

Chartwell Investment Partners first reported a position in GSK in Q4 2013 and held it in 20 quarters. The position peaked at $25.5M in Q2 2017. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • Chartwell Investment Partners reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • Chartwell Investment Partners sold 4,775 GSK shares in Q1 2020, an estimated $280K.
  • Chartwell Investment Partners first reported a position in GSK in Q4 2013 and held it in 20 quarters.
  • Chartwell Investment Partners's GSK position peaked at $25.5M in Q2 2017.
  • 817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Chartwell Investment Partners's 13F filing for Q1 2020, filed 30 Apr 2020.